Journal article

Publication year: 2013

Pages: 117-123

Journal: Aktuelle Urologie

Volume number: 44

Issue number: 2

ISSN: 0001-7868

eISSN: 1438-8820

DOI Link: https://doi.org/10.1055/s-0033-1337934

Publisher: Georg Thieme Verlag

Abstract: 
The prostatitis syndrome is a frequent and complex disease. During the last 40 years the scientific perception has shifted between sometimes success and sometimes disappointment. Whereas acute prostatitis is most frequently considered an infectious disease, in only about 10% of cases with a chronic prostatitis syndrome can pathogens be identified. The bacterial spectrum is similar to that of complicated urinary tract infections with mainly Gram-negative pathogens. In some studies atypical pathogens, such as Chlamydia trachomatis and mycoplasmas, can be found in a considerable proportion. In most cases, however, a multifactorial aetiology is discussed. This has lead to a phenotyping directed multimodal treatment approach, considering the main symptoms. In prostatitis of microbial origin antibiotics, particulary fluorquinolones, are still the therapy of first choice. In the other cases multimodal treatment strategies are used considering evidence-based monotherapeutic studies. The evidence for multimodal combination treatment is still sparse.

Harvard Citation style: Vahlensieck, W., Ludwig, M., Wagenlehner, F., Naber, K. and Fabry, W. (2013) Prostatitis - Diagnostics and Therapy, Aktuelle Urologie, 44(2), pp. 117-123. https://doi.org/10.1055/s-0033-1337934

APA Citation style: Vahlensieck, W., Ludwig, M., Wagenlehner, F., Naber, K., & Fabry, W. (2013). Prostatitis - Diagnostics and Therapy. Aktuelle Urologie. 44(2), 117-123. https://doi.org/10.1055/s-0033-1337934